Stockhead on MSN
Health Check: Telix jumps first hurdle with its advanced prostate cancer therapy trial
In welcome good news, Telix says the first stage of its pivotal prostate cancer therapeutic trial has hit its desired safety ... Read More The post Health Check: Telix jumps first hurdle with its ...
I revved up my longevity protocols and sought out the latest predictive screenings. Was I seizing control of my health or ...
A medical expert has cautioned that a lingering symptom might signal a lesser-known indication of a "silent" illness. According to a specialist, "persistent" back discomfort could suggest pancreatic ...
Hosted on MSN
Man, 46, thought back pain was a pulled muscle but it was symptom of deadly pancreatic cancer
Working long, gruelling hours as a plasterer, Kris Cooke was used to experiencing aches and pains - so he was floored when he was told that his 'backache' was cancer. Earlier this month, Mr Cooke, 46, ...
A newly discovered gene switch may help turn chemotherapy-resistant pancreatic cancer into a treatable disease.
A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...
Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it. The key player, a gene called GATA6, keeps tumours in a more ...
A Lafayette father's battle with stage 4 pancreatic cancer is taking a hopeful turn as he becomes the first in Colorado to receive a newly approved targeted therapy.
Scientists at Duke-NUS Medical School have identified a molecular "switch" that determines whether pancreatic cancer cells resist chemotherapy or respond to it—a finding that could help convert some ...
Sylvester Comprehensive Cancer Center, part of the University of Miami Health System, has sponsored PanCAN PurpleStride for ...
THE WOODLANDS, TX, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (AMIX) (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision ...
The FDA has approved a first-of-its-kind wearable electrical device — Optune Pax (Novocure) — for patients with locally advanced pancreatic cancer, in combination with gemcitabine and nab-paclitaxel.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results